News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Beau Bosko Toskich/mayoclinic.org
Mar 31, 2025, 18:15

Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization

Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida, posted on X about recent paper he and his colleagues co-authored:

“Our international working group is proud to present multidisciplinary recommendations for the treatment of intrahepatic cholangiocarcinoma, colorectal carcinoma, and neuroendocrine carcinoma using Y90 glass microsphere radioembolization.”

Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group

Authors: Marnix Lam, et al.

Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization

 

More posts featuring Beau Bosko Toskich.

Beau Bosko Toskich cancer colorectal carcinoma intrahepatic cholangiocarcinoma Marnix Lam neuroendocrine carcinoma OncoDaily Oncology radioembolization
Special Coverage
Science
Apr 23, 2025, 08:35
Rachit Khandelwal: India’s First POC CAR-T Trial shows 100% CR in B-ALL
Blog
Apr 23, 2025, 08:26
The importance of trusting our instincts and advocating for our health - Digestive Cancers Europe
Blog
Apr 23, 2025, 08:18
FDA is taking bold steps to restore public trust - U.S. FDA
Blog
Apr 23, 2025, 08:09
Shrenik Shah Shares Journey from Cancer Survivor to Global Communicator
Blog
Apr 23, 2025, 07:49
Change Our Future Supports AACR 2025 Program for High School Students
Blog
Apr 23, 2025, 07:47
Julie Fleshman Marks 25 Years at PanCAN, Reflects on Personal and Professional Journey
Blog
Apr 23, 2025, 07:40
Tejas Patil: MET and NF2 Alterations Linked to Primary Resistance in ALK TKI Therapy
Blog
Apr 23, 2025, 07:29
Mandy Davis Aitken: ASCO 2025 Abstract Titles Released Ahead of Early Registration Deadline
Blog
Apr 23, 2025, 07:21
Dipesh Uprety supports Alex Adjei’s candidacy for IASLC President
Blog
Apr 23, 2025, 07:08
Chadi Nabhan Previews Unified Hematopathology Classification Discussion on Healthcare Unfiltered
Blog
Apr 23, 2025, 06:59
Beau Bosko Toskich: MERITS-LT Trial Shows Comparable Survival for HCC Patients Outside UNOS Criteria
Blog
Apr 23, 2025, 06:49
Mark Lewis: Reflects on Light and Levity in Oncology Clinics